These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 7792738

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A detailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detecting factor VIII:C inhibitors in the haemophilia A population of Canada. Association of Hemophilia Centre Directors of Canada. Factor VIII/IX Subcommittee of Scientific and Standardization Committee of International Society on Thrombosis and Haemostasis.
    Giles AR, Verbruggen B, Rivard GE, Teitel J, Walker I.
    Thromb Haemost; 1998 Apr; 79(4):872-5. PubMed ID: 9569207
    [Abstract] [Full Text] [Related]

  • 3. Nijmegen-Bethesda assay to measure factor VIII inhibitors.
    Duncan E, Collecutt M, Street A.
    Methods Mol Biol; 2013 Apr; 992():321-33. PubMed ID: 23546724
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The between-laboratory variation of factor VIII inhibitor testing: the experience of the external quality assessment program of the ECAT foundation.
    Meijer P, Verbruggen B.
    Semin Thromb Hemost; 2009 Nov; 35(8):786-93. PubMed ID: 20169515
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Laboratory assessment of factor VIII inhibitor titer: the North American Specialized Coagulation Laboratory Association experience.
    Peerschke EI, Castellone DD, Ledford-Kraemer M, Van Cott EM, Meijer P, NASCOLA Proficiency Testing Committee.
    Am J Clin Pathol; 2009 Apr; 131(4):552-8. PubMed ID: 19289591
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Analysis of factors which affect the measurement of factor VIII inhibitor by Bethesda method].
    Takahashi Y, Arai M, Fukutake K.
    Rinsho Byori; 1996 May; 44(5):449-55. PubMed ID: 8676565
    [Abstract] [Full Text] [Related]

  • 12. A standardized method for measuring anti-F VIII: C inhibitors in haemophilia A by coagulation inhibition in agarose gel.
    Jorquera JI, Carmona E, Aznar JA, Peiró A, Sánchez-Cuenca JM.
    Thromb Haemost; 1985 Aug 30; 54(2):377-80. PubMed ID: 3936211
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Characterization of antibodies to factor VIII in hemophilia A patients treated by immune tolerance therapy.
    Scandella D, Reyes H, Felch M, Sakurai Y.
    Haematologica; 2000 Oct 30; 85(10 Suppl):86-8. PubMed ID: 11187882
    [Abstract] [Full Text] [Related]

  • 15. Acquired haemophilia: functional study of antibodies to Factor VIII.
    Allain JP, Gaillandre A, Frommel D.
    Thromb Haemost; 1981 Jun 30; 45(3):285-9. PubMed ID: 6792741
    [Abstract] [Full Text] [Related]

  • 16. Treatment of patients with hemophilia A and inhibitors to factor FVIII with cimetidine.
    Ambriz Fernandez R, Quintana Gonzalez S, Martinez Murillo C, Dominguez Garcia V, Rodriguez Moyado H, Collazo Jaloma J.
    Arch Med Res; 1996 Jun 30; 27(1):15-8. PubMed ID: 8867361
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Validation of 4% albumin as a diluent in the Bethesda Assay for FVIII inhibitors.
    Kershaw GW, Chen LS, Jayakodi D, Dunkley SM.
    Thromb Res; 2013 Jun 30; 132(6):735-41. PubMed ID: 24119613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.